US Patent Issued to Fred Hutchinson Cancer Center, University of Rochester, Leiden University Medical Center on May 12 for "Methods for alleviating facioscapulohumeral dystrophy (FSHD) by an antisense nucleic acid molecule inhibiting the expression of double homeobox 4 (DUX4)" (Dutch, American Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,396, issued on May 12, was assigned to Fred Hutchinson Cancer Center (Seattle), University of Rochester (Rochester, N.Y.) and Leiden University Medical Center (Leiden, Netherlands).

"Methods for alleviating facioscapulohumeral dystrophy (FSHD) by an antisense nucleic acid molecule inhibiting the expression of double homeobox 4 (DUX4)" was invented by Silvere M. van der Maarel (Leiden, Netherlands), Stephen J. Tapscott (Seattle), Rabi Tawil (Rochester, N.Y.), Richard J.L.F. Lemmers (Leiden, Netherlands), Linda Geng (Seattle) and Lauren Snider (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, the invention provides a method of scre...